No Picture
News

Ex-Altimmune chief Bill Enright lands CEO role at Vaccitech; Reata poaches Alnylam CFO Manmeet Soni

Bill Enright
? After a stint consulting for Avidea Technologies, Bill Enright is back at the CEO game Vaccitech?s new chief. Like Altimmune ? which Enright led for 11 years ? Vaccitech has a dual focus on cancer and infectious diseases. The appointment… […]

No Picture
News

Worst. biotech. deal. ever? Turns out AbbVie has plenty of competition for that title

Buying any late-stage drug in a biotech buyout can be fraught with danger ? and ripe for humiliation. AbbVie got a lesson on that with the final failure for Rova-T, a drug they forked over $5.8 billion in cash and equity to get its hands on.
But was th… […]

No Picture
News

Menlo Therapeutics to Present at the HC Wainwright 21st Annual Global Investment Conference

REDWOOD CITY, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), today announced that Kristine Ball,… […]